Research Capital Corporation analyst Andre Uddin says Spectral Medical (Spectral Medical Stock Quote, Chart, News, Analysts, Financials TSX:EDT) has reached a key regulatory catalyst with the submission of its Premarket Approval application to the U.S. Food and Drug Administration for its PMX columns. In a May 29 update, Uddin maintained his “Speculative Buy” rating and […]
Roth Capital analyst Boobalan Pachaiyappan lowered his target on Capricor Therapeutics (Capricor Therapeutics Stock Quote, Chart, News, Analysts, Financials NASDAQ:CAPR) to $38.00 from $43.00 in a May 14 report, while maintaining a “Buy” rating, after removing an expected $80-million NS Pharma milestone and pushing his U.S. Deramiocel launch assumption to 2027. Pachaiyappan said he remains […]
Share
Tweet
Share
